Table 1.
Relation Between LINC00501 and Pathological Data About the Patients
| Factor | Relative Expression of LINC00501 | P-value | ||
|---|---|---|---|---|
| High Expression (n=25) | Low Expression (n=25) | |||
| Sex | ||||
| Male (n=35) | 18 | 17 | 0.758 | |
| Female (n=15) | 7 | 8 | ||
| Age (Y) | ||||
| ≥60 (n=26) | 12 | 14 | 0.571 | |
| <60 (n=24) | 13 | 11 | ||
| Smoking history | ||||
| Yes (n=35) | 18 | 17 | 0.758 | |
| No (n=15) | 7 | 8 | ||
| Differentiation | ||||
| Poor (n=20) | 14 | 6 | 0.021 | |
| Well/moderate (n=30) | 11 | 19 | ||
| Clinical staging | ||||
| I–II stage (n=32) | 12 | 20 | 0.018 | |
| III–IV stage (n=18) | 13 | 5 | ||
| Pathological type | ||||
| Squamous cell carcinoma (n=25) | 12 | 13 | 0.777 | |
| Adenocarcinoma (n=25) | 13 | 12 | ||
| Tumor size (cm) | ||||
| ≥3 (n=24) | 15 | 9 | 0.089 | |
| <3 (n=26) | 10 | 16 | ||
| Distant metastasis | ||||
| Yes (n=23) | 15 | 8 | 0.047 | |
| No (n=27) | 10 | 17 | ||
| Tumor subtypes | ||||
| Adenocarcinoma (n=31) | 14 | 17 | 0.382 | |
| Squamous cell carcinoma (n=19) | 11 | 8 | ||
| EGFR mutation | ||||
| Mutation (n=18) | 10 | 8 | 0.556 | |
| No mutation (n=32) | 15 | 17 | ||